Buy Ajanta Pharma, target Rs 1065: Jayesh Bhanushali

Jayesh Bhanushali of IIFL has a buy call on Ajanta Pharma Ltd. with a target price of Rs 1065.0 . The current market price of Ajanta Pharma Ltd. is Rs 1041.15. Time period given by the analyst is Intra Day when Ajanta Pharma Ltd. price can reach defined target. Jayesh Bhanushali recommended to keep stoploss at Rs 988. Ajanta Pharma Ltd., incorporated in 1979, has a market cap of Rs 9084.53 crore.
Ajanta Pharma Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 1731.36 Crore to Sales Value (97.67 % of Total Sales), Export Incentives which contributed Rs 38.93 Crore to Sales Value (2.19 % of Total Sales) and Other Operating Revenue which contributed Rs 2.33 Crore to Sales Value (0.13 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 611.94 Crore, up 18.79 % from last quarter Sales of Rs 515.16 Crore and up 19.76 % from last year same quarter Sales of Rs 510.99 Crore Company has reported net profit after tax of Rs 114.63 Crore in latest quarter. The company’s top management includes Dr.Anjana Grewal, Mr.Chandrakant M Khetan, Mr.K H Viswanathan, Mr.Madhusudan B Agrawal, Mr.Mannalal B Agrawal, Mr.Prabhakar R Dalal, Mr.Rajesh M Agrawal, Mr.Yogesh M Agrawal. Company has B S R & Co. LLP as its auditoRs As on 30-06-2019, the company has a total of 87,254,770 shares outstanding.